Continuous glucose monitors (CGMs), insulin pumps and insulin pump consumables: Procurement status


Find the latest information on Pharmac’s procurement process for continuous glucose monitoring (CGM) devices, insulin pumps and insulin pump consumables.

Request for Proposals released

On 11 July 2023, we announced our request for proposals (RFP) to fund CGMs, insulin pumps and consumables. Suppliers can now send Pharmac proposals responding to what we have asked for. The RFP is now closed. 

For many of the 17,000 New Zealanders living with type 1 diabetes having funded access to these devices would be life changing. We are really pleased to be at the stage where we can consider funding CGMs, thanks to receiving our largest budget increase in 2022

As with all commercial processes, there is some uncertainty. The outcome depends on what bids we receive from suppliers. However, we think funding CGMs will be possible.

Media release: Pharmac seeking bids from suppliers for continuous glucose monitors, insulin pumps and consumables

Request for Proposals (closed 18 August 2023)

Requests for Proposals - one way Pharmac funds treatments

Advice from the experts

We consulted our Diabetes Specialist Advisory Committee. They have provided a range of advice on everything we need to consider when evaluating RFP bids from suppliers.

What happens after the RFP closes?

Once the RFP closes an evaluation committee, including Pharmac staff, clinical experts, and consumer representatives will meet to consider the proposals received.

Pharmac will use information gathered during the evaluation, alongside the Factors for Consideration, to select the preferred suppliers. At this stage we will continue with the usual funding process and consult with the public, giving all New Zealanders a chance to give feedback.

We will carefully consider all consultation feedback and make any necessary changes to what we are proposing to fund. The Pharmac Board will then consider all consultation feedback along with the proposal and decide on the outcome.

The Pharmac Board

Once a decision is made, our team will ensure there are measures in place to support any changes that result from this process. For example, organising education resources that outline next steps for clinicians and consumers.

How long will it take?

Pharmac understands people would like to know how long this procurement process will take. We are working to the following milestones and will update this page if there are changes.

Milestone Date
FPO release Complete (Feb 2023)
Clinical advice Complete (April 2023)

Publishing records of clinical advice from the diabetes Specialist Advisory Committe

Complete (July 2023)
RFP release Complete (July 2023)
Supplier briefing Complete (July 2023)
Stakeholder briefing Complete (August 2023)
Bids close Complete (August 2023)
Evaluation committee meetings and seeking further clinical advice September 2023
Consultation period TBD
Pharmac Board meeting TBD
Decision notification date TBD
Provisional implementation date  TBD 2024

Who to contact

We will update this page as more information becomes available. 

Sign up for email notifications(external link)

If your question is not answered here, email 

More information

Application Tracker details for CGMs:

Dexcom(external link)

FreeStyle Libre(external link)

Medtronic(external link)